Accessibility Menu
Electromed logo

Electromed(NYSEMKT) ELMD

Current Price$40.48
Market Cap$338.49MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2010)+927%
5 Year+242%
1 Year+124%
1 Month+5%
Electromed last closing stock price
MetricPriceDate
Last closeUSD 40.522026-07-21
Electromed stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-8.62%USD 44.342026-07-14
1 month+4.76%USD 38.682026-06-18
3 month+56.51%USD 25.892026-04-22
Year to date+39.15%USD 29.122025-12-31
1 year+123.62%USD 18.122025-07-21
3 year+268.7%USD 10.992023-07-21
5 year+241.94%USD 11.852021-07-22
Since inception+927.14%USD 3.982010-08-13

Electromed Financials at a Glance

Market Cap

$338.49MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$71.75M

Net Income (TTM)

$10.10M

EPS (TTM)

$1.16

P/E Ratio

35.13

Dividend

$0.00

Beta (Volatility)

0.47 (Low)

Price

$40.48

Volume

4,625

Open

$40.90

Previous Close

$40.48

Daily Range

$39.48 - $41.09

52-Week Range

$17.73 - $47.40

Estimated Earnings Date

Aug 25, 2026

ELMD News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Electromed

Electromed makes medical devices that help people clear their lungs. Its main product, SmartVest, helps patients breathe easier at home. The company’s technology supports those with chronic lung conditions.

Products and Services

  • SmartVest Airway Clearance System: Main product for home use, helps clear mucus for people with lung diseases; homecare sales are 89.9% of revenue (three months ended March 31, 2025).
  • SmartVest Clearway: Latest generation device with touch screen and lighter design, used by patients with chronic lung problems.
  • SmartVest SQL System: Previous generation device, still used by many patients needing airway clearance.
  • SmartVest Connect: Wireless portal for therapy management, lets patients and doctors track treatment progress.
  • Single-Use SmartVest and Wrap: Disposable options for hospitals and clinics, used in short-term or acute care settings.

Growth and Expansion

  • Launched SmartVest Clearway in late 2022, expanding product line with FDA clearance.
  • SmartVest Connect is a wireless technology platform that supports remote therapy management.
  • Expanded direct sales force from 59 to 62 field employees between March 2024 and March 2025.
  • Investment in direct-to-consumer marketing increased for the three months ended March 31, 2025.
  • Operates internationally, but most revenue comes from the United States.

What Makes Electromed Stand Out

Electromed focuses on a single, specialized product line for airway clearance. Its direct sales approach and insurance reimbursement support help drive adoption. The company integrates wireless technology to improve patient monitoring and therapy management.

Five Things You Need to Know

  • Revenue was $17 million in QQ1 2026, up 15.1% from QQ1 2025.
  • Gross profit was $13 million in QQ1 2026, up 14.8% year-over-year.
  • Net income was $2 million in QQ1 2026, up 44.9% from QQ1 2025.
  • Homecare sales made up nearly 90% of revenue in early 2025.
  • Cash and cash equivalents were $15.24 million as of March 31, 2025.

Bottom Line

Electromed has grown by focusing on specialized lung therapy devices and direct sales. Its steady expansion and product updates support its position in the medical device market.

AI Generated • Apr 16, 2026

Industry

Healthcare Equipment and Supplies

Employees

180

CEO

James L. Cunniff

Headquarters

New Prague, MN 56071, US

ELMD Financials

Key Financial Metrics (TTM)

Gross Margin

78.44%

Operating Margin

18.55%

Net Income Margin

14.08%

Return on Equity

22.14%

Return on Capital

22.74%

Return on Assets

16.99%

Earnings Yield

2.85%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$338.49MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

8.28M

Volume

4.63K

Avg. Volume

88.08K

Financials (TTM)

Gross Profit

$56.28M

Operating Income

$13.31M

EBITDA

$14.78M

Operating Cash Flow

$10.53M

Capital Expenditure

-$304.00K

Free Cash Flow

$10.23M

Cash & ST Invst.

$16.99M

Total Debt

$81.00K

Electromed Performance Analysis

Electromed annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-06-30USD 41,659,000N/A
20232023-06-30USD 48,067,00015.4%
20242024-06-30USD 54,716,00013.8%
20252025-06-30USD 64,000,00017.0%
Electromed sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42025-06-3010.9%
Q12025-09-30-2.9%
Q22025-12-3111.9%
Q32026-03-31-1.7%
Electromed annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-06-30USD 0.26N/A
20232023-06-30USD 0.3638.4%
20242024-06-30USD 0.5859.7%
20252025-06-30USD 0.8545.5%
Electromed sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42025-06-3019.0%
Q12025-09-30N/A
Q22025-12-3128.0%
Q32026-03-319.4%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q3 2026YOY CHG

Revenue

$18.58M

+18.4%

Gross Profit

$14.64M

+19.7%

Gross Margin

78.83%

N/A

Market Cap

$338.49MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$1.88M

N/A

Employees

180

N/A

Net Income

$3.00M

+58.8%

EBITDA

$4.15M

+61.9%

Quarterly Fundamentals

Name
Q3 2026YOY CHG

Total Cash

$16.99M

+11.5%

Total Debt

$81.00K

N/A

Accounts Receivable

$29.35M

+15.1%

Inventory

$3.30M

+11.0%

Long Term Debt

$81.00K

N/A

Short Term Debt

$0.00

N/A

Return on Assets

16.99%

N/A

Return on Invested Capital

27.02%

N/A

Free Cash Flow

$3.33M

+44.1%

Operating Cash Flow

$3.48M

+67.6%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
VMDViemed Healthcare, Inc.
$11.92-0.42%
PROFProfound Medical Corp.
$6.91+1.47%
INGNInogen, Inc.
$6.43+0.47%
TLSITriSalus Life Sciences, Inc.
$4.34+0.70%

Trending Stocks

Symbol / CompanyPricePrice Chg
ONDSOndas
$7.66+0.11%
PATHUiPath
$12.04-0.01%
TAT&T
$22.26+0.01%
INTCIntel
$105.45+0.09%

Questions About ELMD

What is the current price of Electromed?

Electromed is trading at $40.48 per share.

What is the 52-week range for Electromed?

Over the past 52 weeks, Electromed has traded between $17.73 and $47.40.

How much debt does Electromed have?

As of the most recent reporting period, Electromed reported total debt of $0.00.

How much cash does Electromed have on hand?

Electromed reported $16.99M in cash and cash equivalents in its most recent financial results.

What is Electromed’s dividend yield?

Electromed does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.